Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0056 | 0.0273 | 0.0449 |
Echinococcus multilocularis | acetylcholinesterase | 0.02 | 0.6066 | 1 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0193 | 0.579 | 0.9545 |
Echinococcus granulosus | carboxylesterase 5A | 0.02 | 0.6066 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.02 | 0.6066 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.02 | 0.6066 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.0089 | 0.0146 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0056 | 0.0273 | 0.0449 |
Loa Loa (eye worm) | MBCTL1 | 0.0056 | 0.0273 | 0.0449 |
Echinococcus granulosus | acetylcholinesterase | 0.02 | 0.6066 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.0089 | 0.0146 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0193 | 0.579 | 0.9545 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0056 | 0.0273 | 0.0273 |
Echinococcus granulosus | acetylcholinesterase | 0.02 | 0.6066 | 1 |
Onchocerca volvulus | 0.0049 | 0 | 0.5 | |
Brugia malayi | Carboxylesterase family protein | 0.02 | 0.6066 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0273 | 0.0449 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0056 | 0.0273 | 0.0449 |
Loa Loa (eye worm) | carboxylesterase | 0.02 | 0.6066 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.02 | 0.6066 | 1 |
Echinococcus multilocularis | carboxylesterase 5A | 0.02 | 0.6066 | 1 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0056 | 0.0273 | 0.0449 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0056 | 0.0273 | 0.0449 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.02 | 0.6066 | 1 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0049 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.0089 | 0.0146 |
Echinococcus multilocularis | acetylcholinesterase | 0.02 | 0.6066 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0089 | 0.0146 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.02 | 0.6066 | 0.6066 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.7781 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.